NextFin news, Health and Human Services Secretary Robert F. Kennedy Jr. appeared before the Senate Finance Committee on Thursday, September 4, 2025, in Washington, D.C., where he faced sharp bipartisan criticism for his recent vaccine policy changes and public statements.
During his testimony, Kennedy defended his decision to overhaul the Centers for Disease Control and Prevention (CDC), including the replacement of all 17 original members of the Advisory Committee on Immunization Practices (ACIP) with new appointees, some of whom have expressed anti-vaccination views. This restructuring has raised concerns among public health officials and lawmakers about the future of vaccine guidance in the United States.
In August, Kennedy dismissed Susan Monarez, the CDC director who had served only one month, reportedly due to her refusal to support his vaccine recommendations. Monarez is scheduled to testify before Congress next week to address her firing and her disagreements with Kennedy over vaccine policies.
Kennedy's vaccine policy changes include ending COVID-19 vaccine mandates nationwide and altering recommendations for COVID-19 vaccinations. In May, he announced that the CDC would no longer recommend COVID-19 vaccines for healthy children and pregnant women. On August 27, he authorized new COVID-19 vaccine formulations for the 2025-26 season, approving Moderna for individuals six months and older with underlying conditions, Pfizer for those five and older with underlying conditions, and Novavax for those 12 and older with underlying conditions. The CDC defines underlying conditions to include pregnancy, diabetes, obesity, cancer, disabilities, and mental health conditions. Additionally, vaccines are approved for all individuals aged 65 and older.
As the United States enters the peak season for influenza and COVID-19, medical experts have expressed concern that ending vaccine mandates and limiting recommendations could increase risks for vulnerable populations. The Food and Drug Administration recently approved the 2025-26 COVID-19 vaccine formula, which is becoming available across the country this September.
Further controversy arose on September 3 when Florida announced plans to become the first state to remove vaccine mandates for diseases including hepatitis B, Hib influenza, and chickenpox. Florida's Surgeon General Joseph Ladapo stated that the state would empower parents to make health decisions for their children, a move supported by Governor Ron DeSantis but criticized by public health experts who warn it could increase the spread of communicable diseases. This policy change is expected to take effect in approximately 90 days.
The vaccine policy shifts under Kennedy's leadership have sparked widespread debate and concern among lawmakers, health professionals, and the public as the nation prepares for the upcoming respiratory virus season.
Explore more exclusive insights at nextfin.ai.
